Production of LacZ Inducible T Cell Hybridoma Specific for Human and Mouse gp10025-33 Peptides

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Cafri, Gal ^a   Sharbi Yunger, Adi ^a   Tzehoval, Esther ^a   Eisenbach, Lea ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; GLYCOPROTEIN GP 100; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN; MELANOMA ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CD8+ T LYMPHOCYTE; CELL SPECIFICITY; CELL SURFACE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; HYBRIDOMA; MEMBRANE MARKER; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PROTEIN EXPRESSION; TUMOR CELL LINE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; DENDRITIC CELLS; FLOW CYTOMETRY; GP100 MELANOMA ANTIGEN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; HYBRIDOMAS; INTERLEUKIN-2; LAC OPERON; MICE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84873263576     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055583     Document Type: Article

References (11)

1. Malarkannan S, Mendoza LM, Shastri N, (2001) Generation of Antigen-Specific, LacZ-Inducible T-Cell Hybrids. Methods in molecular biology 156: 265-272.
2. Sanderson S, Shastri N, (1994) LacZ inducible, antigen/MHC-specific T cell hybrids. International immunology 6: 369-376 Available: http://www.ncbi.nlm.nih.gov/pubmed/8186188. Accessed 2013 Jan 9.
3. Shaw JP, Utz PJ, Durand DB, Toole JJ, Emmel EA, et al. (1988) Identification of a putative regulator of early T cell activation genes. Science 241: 202-205.
4. Durand DB, Bush MR, Morgan JG, Weiss A, Crabtree GR, (1987) A 275 basepair fragment at the 5′ end of the interleukin 2 gene enhances expression from a heterologous promoter in response to signals from the T cell antigen receptor. Journal of experimental medicine 165: 395-407.
5. Karttunen J, Shastri N, (1991) Measurement of ligand-induced activation in single viable T cells using the lacZ reporter gene. Proceedings of the National Academy of Sciences of the United States of America 88: 3972-3976.
6. Overwijk WW, Tsung A, Irvine KR, Parkhurst MR, Goletz TJ, et al. (1998) gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand. Journal of experimental medicine 188: 277-286 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2212458&tool=pmcentrez&rendertype=abstract. Accessed 2010 Aug 10.
7. Karttunen J, Sanderson S, Shastri N, (1992) Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proceedings of the National Academy of Sciences of the United States of America 89: 6020-6024 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=402130&tool=pmcentrez&rendertype=abstract. Accessed 2011 Jun 16.
8. Shen Z, Reznikoff G, Dranoff G, Rock K, (1997) Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. Journal of Immunology 158: 2723-2730 Available: http://www.jimmunol.org/cgi/content/abstract/158/6/2723. Accessed 2011 Oct 4.
9. Porgador A, Tzehoval E, Vadai E, Feldman M, Eisenbach L, (1995) Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases. Cancer research 55: 4941-4949 Available: http://www.ncbi.nlm.nih.gov/pubmed/7585534. Accessed 2011 Oct 17.
10. Falo LD, Kovacsovics-Bankowski M, Thompson K, Rock KL, (1995) Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity. Nature Medicine 1: 649-653 Available: http://dx.doi.org/10.1038/nm0795-649. Accessed 2011 Oct 17.
11. Katz A, Feldman M, Eisenbach L, (1992) The use of [35S]methionine as a target cell label in long term cytotoxic assays. Journal of immunological methods 149: 255-260 Available: http://www.ncbi.nlm.nih.gov/pubmed/1593137. Accessed 2012 Jan 9.